Skip to main content
Clinical Trials/TCTR20190407001
TCTR20190407001
Completed
Phase 1

Immune Responses in Mothers of Term and Preterm Low-Birth-Weight: Levels of CD4+ and CD8+ T Cells in Gingival Granulation Tissue

Selcuk University, BAP0 sites67 target enrollmentApril 7, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Preterm low birth weight
Sponsor
Selcuk University, BAP
Enrollment
67
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 7, 2019
End Date
October 3, 2010
Last Updated
last year
Study Type
Observational
Sex
Female

Investigators

Sponsor
Selcuk University, BAP

Eligibility Criteria

Inclusion Criteria

  • Presence of at least 20 teeth in their mouth and at least two teeth with \>5mm probing depth and clinical attachment loss; no history of initial periodontal therapy including scaling and root planing at least six weeks prior to the study.

Exclusion Criteria

  • Women presenting risk factors to preterm/low\-birth\-weight: history of diseases including diabetes mellitus, genitourinary tract infections or HIV infection, previous multiple gestations, previous preterm birth/low\-birth\-weight infants, in vitro fertilization procedures, placental or cervical or uterine abnormalities, history of infertility, history of illegal drug use, history of human immunodefficiency virus type I or hemoglobin levels less than 8 mg/dl following delivery and medical conditions that required antibiotics prophylaxis.

Outcomes

Primary Outcomes

Not specified

Similar Trials